320 related articles for article (PubMed ID: 10211995)
1. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
Sengupta S; Gherardi E; Sellers LA; Wood JM; Sasisekharan R; Fan TP
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):69-75. PubMed ID: 12524227
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.
Gille J; Khalik M; König V; Kaufmann R
J Invest Dermatol; 1998 Dec; 111(6):1160-5. PubMed ID: 9856833
[TBL] [Abstract][Full Text] [Related]
4. Effects of coronary artery disease on expression and microvascular response to VEGF.
Métais C; Li J; Li J; Simons M; Sellke FW
Am J Physiol; 1998 Oct; 275(4):H1411-8. PubMed ID: 9746492
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
Mandriota SJ; Pepper MS
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
[TBL] [Abstract][Full Text] [Related]
7. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
Van Belle E; Witzenbichler B; Chen D; Silver M; Chang L; Schwall R; Isner JM
Circulation; 1998 Feb; 97(4):381-90. PubMed ID: 9468212
[TBL] [Abstract][Full Text] [Related]
8. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.
Kroon ME; Koolwijk P; van der Vecht B; van Hinsbergh VW
Blood; 2000 Oct; 96(8):2775-83. PubMed ID: 11023511
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
[TBL] [Abstract][Full Text] [Related]
10. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
Reisinger K; Kaufmann R; Gille J
J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
[TBL] [Abstract][Full Text] [Related]
11. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
12. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
13. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
14. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?
Villars F; Bordenave L; Bareille R; Amédée J
J Cell Biochem; 2000 Sep; 79(4):672-85. PubMed ID: 10996857
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
[TBL] [Abstract][Full Text] [Related]
16. Neovascularization of the Xenopus embryo.
Cleaver O; Tonissen KF; Saha MS; Krieg PA
Dev Dyn; 1997 Sep; 210(1):66-77. PubMed ID: 9286596
[TBL] [Abstract][Full Text] [Related]
17. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
18. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
Paciucci R; Vilá MR; Adell T; Díaz VM; Torà M; Nakamura T; Real FX
Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
Pepper MS; Ferrara N; Orci L; Montesano R
Biochem Biophys Res Commun; 1991 Dec; 181(2):902-6. PubMed ID: 1755866
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
Wojta J; Nakamura T; Fabry A; Hufnagl P; Beckmann R; McGrath K; Binder BR
Blood; 1994 Jul; 84(1):151-7. PubMed ID: 7517205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
